ArticleTranslational oncology2017

Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon.

Jiayi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.